Sherry L. Xu
- Physiology top 5%
- Molecular Biology top 10%
- Neurology top 2%
- Cellular and Molecular Neuroscience top 5%
- Pharmacology top 5%
- Co-authors
- Costantino IadecolaFangyi ZhangKarl Wah Keung TsimM. Elizabeth RossTina Ting-Xia DongRoy C.Y. ChoiKevin Y. ZhuCathy W.C. Bi
- Topics
- Computational Drug Discovery Methods (4 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)Medicinal Plants and Bioactive Compounds (4 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Sherry L. Xu
40 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 125
- Physiology 727
- Molecular Biology 717
- Neurology 403
- Cellular and Molecular Neuroscience 363
- Pharmacology 336
Countries citing papers authored by Sherry L. Xu
This map shows the geographic impact of Sherry L. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry L. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry L. Xu more than expected).
Fields of papers citing papers by Sherry L. Xu
This network shows the impact of papers produced by Sherry L. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry L. Xu. The network helps show where Sherry L. Xu may publish in the future.
Co-authorship network of co-authors of Sherry L. Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Sherry L. Xu. A scholar is included among the top collaborators of Sherry L. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry L. Xu. Sherry L. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 23 | |
| 3 | 16 | |
| 4 | 12 | |
| 5 | 17 | |
| 6 | 45 | |
| 7 | 18 | |
| 8 | 1 | |
| 9 | 65 | |
| 10 | 34 | |
| 11 | 41 | |
| 12 | 23 | |
| 13 | 39 | |
| 14 | 23 | |
| 15 | 20 | |
| 16 | 101 | |
| 17 | 83 | |
| 18 | 75 | |
| 19 | 410 | |
| 20 | 442 |
About Sherry L. Xu
Sherry L. Xu is a scholar working on Developmental Neuroscience, Complementary and alternative medicine and Neurology, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Medicinal Plants and Bioactive Compounds (4 papers). The work is most often cited by research in Neurology (403 citations), Biological Psychiatry (95 citations) and Physiology (727 citations). Sherry L. Xu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Costantino Iadecola, Fangyi Zhang, Karl Wah Keung Tsim, M. Elizabeth Ross, Tina Ting-Xia Dong, Roy C.Y. Choi, Kevin Y. Zhu, Cathy W.C. Bi, Ava J.Y. Guo and Steven G. Younkin. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.